43 of normalization of the EEG at 12 months (ESX, 77%; VPA, 83%; and LTG, 64%), retention rate through the treatment period, and adverse-event rates (ESX, 25%; VPA, 29%; and LTG, 14%). Frequent causes of AED withdrawal because of adverse events were GI complaints for ESX (10%), GI complaints (5%) and alopecia (7%) for VPA, and rash for LTG (5%).
YIELD OF ABNORMAL CT WITH FIRST COMPLEX FS
Physicians in Emergency Medicine, Pediatric Neurology, and Radiology at Children's Hospital Boston, MA studied the risk of intracranial pathology requiring immediate intervention among patients presenting in the ED with a first complex febrile seizure (CFS). Of a total of 526 patients identified with a first CFS between 1995 and 2008, 268 (50.4%) had emergent head CT imaging. Four patients had a clinically significant finding: 2 had intracranial hemorrhage, 1 had ADEM, and 1 had focal cerebral edema. The risk of intracranial pathology was 4 (0.8%). Three of the 4 had other obvious findings: nystagmus, emesis, altered mental status, persistent hemiparesis, bruises suggestive of inflicted injury. Patients presenting with more than one seizure in 24 hours are at very low risk. COMMENT. This study suggests that emergency neuroimaging may be unnecessary for children who present in the ED with a first CFS, uncomplicated by other acute signs of neuropathology. Focal and prolonged CFS may be more predictive of pathology than the multiple seizure type, especially when associated with prolonged postictal state.
In a retrospective study of 100 consecutive febrile seizure patient-visits to a university affiliated tertiary hospital, head CT was obtained in 18 patients at time of visit, with normal results in 17 (1 patient had mastoiditis). MRIs performed in 4 patients with CFS were normal. Of the 18 with CT scans, 4 had simple FS (5.8% of 77) and 14 had 
METABOLIC DISORDERS COGNITIVE OUTCOME OF INFANTS WITH POMPE DISEASE RECEIVING ENZYME-REPLACEMENT THERAPY
Researchers at University Medical Center, Rotterdam, the Netherlands, and University of Leuven, Belgium prospectively assessed cognitive function in 10 children with classic infantile Pompe disease who had been treated with enzyme-replacement therapy (ERT) since 1999. Median age at diagnosis was 0.7 months (range 0.1-6.2 months). ERT was started at a median age of 2.3 months (range 0.1-8.3 months). Developmental scores in the first 4 years of life ranged from above average to severe delay. The type of IQ test used, severity of motor problems, speech/language delay, and age at start of ERT influenced the developmental scores. At young age poor motor functioning may interfere with reliable assessment of cognition. Scores in 5 children tested after 5 years of age ranged between normal and mild developmental delay. Nine children had hearing deficits and 7 had impaired vision. Brain imaging in 6 patients revealed periventricular white matter abnormalities in 4. COMMENT. Pompe disease (glycogen storage disease type II; acid maltase deficiency) is an autosomal recessive, progressive metabolic myopathy due to lysosomal a-glucosidase deficiency. Enzyme activity is reduced to <1%, and glycogen stores accumulate in skeletal, cardiac, and smooth muscle, and in the brain. Pompe presents with neonatal hypotonia, macroglossia, cardiomegaly, and hepatomegaly. Patients usually die before 1 year of age with cardiorespiratory failure or aspiration pneumonia. ERT, using recombinant human a-glucosidase, improves motor development and lengthens life expectancy, but ERT does not cross the blood-brain-barrier. Glycogen is stored in the CNS and may cause cognitive deficits. This study shows that children treated with ERT who survive to school age may have normal to mildly delayed cognitive development. Testing of young children < 4 years is largely dependent on motor function. Since muscle involvement and weakness are prominent features of Pompe disease and are resistant to ERT, cognitive development will be underestimated in children younger than 5 years.
Early treatment and newborn screening for Pompe disease are recommended. 
